We are live on ! Find out more
CC

Caxton Corporation Portfolio holdings

AUM $4.02M
1-Year Est. Return 256.08%
This Fund
S&P 500
This Quarter Est. Return
-9.68%
1 Year Est. Return
+256.08%
3 Year Est. Return
+777.99%
5 Year Est. Return
+744.68%
10 Year Est. Return
+18,621.85%
AUM
$80.4M
AUM Growth
-$41.9M
Cap. Flow
-$30.5M
Cap. Flow %
-37.98%
Top 10 Hldgs %
79.62%
Holding
53
New
1
Increased
2
Reduced
24
Closed
16

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$3.99M
2
ACLX
Arcellx
ACLX
+$1.49M
3
ELEV
Elevation Oncology
ELEV
+$52K

Top Sells

Rank Stock Value
1
CRDF icon
Cardiff Oncology
CRDF
+$15.2M
2
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
+$5.72M
3
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
+$5.55M
4
LUXA
Lux Health Tech Acquisition Corp. Class A Common Stock
LUXA
+$1.96M
5
EFA icon
iShares MSCI EAFE ETF
EFA
+$1.5M

Sector Composition

Rank Sector Weight
1 Healthcare 57.31%
2 Financials 10.5%
3 Communication Services 5.09%
4 Technology 4.29%
5 Consumer Discretionary 1.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SRRA
51
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
– –
-262,969
Closed -$5.72M
CTIC
52
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
– –
-2,239,300
Closed -$5.55M
PICC.U
53
DELISTED
Pivotal Investment Corporation III Units, each consisting of one share of Class A common stock and one-fifth of one redeemable warrant
PICC.U
– –
-16,800
Closed -$166K
1 2
3

Similar funds

PCM
Pathway Capital Management Irvine, California $4.3M AUM 62.8% 1-Year Est. Return
RA
Ritter Alpha New York $4.78M AUM
CGA
Compound Global Advisors Mercer Island, Washington $3.22M AUM 30.08% 1-Year Est. Return
HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
ABA
American Beacon Advisors Irving, Texas $5.08M AUM 20.11% 1-Year Est. Return
UOMF
University of Maryland Foundation Adelphi, Maryland $5.1M AUM 10.69% 1-Year Est. Return
KI
Khan Imran $2.93M AUM
1IC
1922 Investment Company Houston, Texas $2.92M AUM 1.93% 1-Year Est. Return

Caxton Corporation's Q1 2022 Portfolio in Review

As of Q1 2022, Caxton Corporation held 53 positions worth $80.4M, down 34% from $122M the previous quarter. Its ten largest holdings account for 80% of the portfolio.

Caxton Corporation withdrew a net $30.5M in Q1 2022, closing 16 positions and reducing 24 holdings. Its most notable exit was Cardiff Oncology, an estimated $15.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 57% of assets, down from 66% a quarter earlier, followed by Financials and Communication Services.

Against the trend, Caxton Corporation opened a new position in Arcellx worth $1.25M.

  • Caxton Corporation's largest Q1 2022 buy was Arcellx: 88,820 shares worth $1.25M.
  • Caxton Corporation added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $3.99M increase.
  • Caxton Corporation's biggest Q1 2022 reduction was Xeris Biopharma Holdings, cutting an estimated $663K.
  • Caxton Corporation fully exited Cardiff Oncology in Q1 2022, selling an estimated $15.2M.
  • Caxton Corporation's ten largest holdings make up 80% of its $80.4M portfolio in Q1 2022.
  • Caxton Corporation opened 1 new position and closed 16 in Q1 2022.
  • Caxton Corporation's portfolio value fell 34% quarter-over-quarter to $80.4M.

Based on Caxton Corporation's 13F filing for Q1 2022, filed 16 May 2022.